Loading...
The U.S. Medical Eligibility Criteria for Contraceptive Use, first published in 2010 by the CDC (JW Womens Health Jun 24 2010), continue to evolve as new data are incorporated. Now, a new update provides guidance about postpartum contraceptive use. The immediate postpartum period — defined as the first 42 days following delivery — is associated with 22- to 84-fold higher risk for venous thromboembolism (VTE) than that in nonpregnant or nonpostpartum reproductive-age women. The modest excess risk for VTE associated with estrogen-containing contraceptives has prompted a recommendation that use of these contraceptive options be restricted during the postpartum period. Fertile ovulation is unlikely until at least 42 days postpartum, lending sup…